Related Articles
Optimal use of current chemotherapy in multimodality therapy for advanced colorectal cancer
Factors favouring long‑term survival following recurrence in ovarian cancer
Disease-adapted relapse therapy for ovarian cancer: results of a prospective study.
Chemotherapy in metastatic malignant triton tumor: Report on two cases
Prognostic factors for surgical outcome and survival in 447 women treated for advanced (FIGO-stages III-IV) epithelial ovarian carcinoma